An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
about
Current perspectives in the treatment of resistant schizophreniaAugmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study.Clozapine: Current perspective.Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension studyTreating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophreniaRole of aripiprazole in treatment-resistant schizophrenia.Safety and tolerability of antipsychotic polypharmacy.Clozapine and co-prescribed psychotropics: a short report.Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.Does antipsychotic polypharmacy increase the risk for metabolic syndrome?Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.The Fatigue Symptom Inventory: a systematic review of its psychometric properties.Antipsychotic polypharmacy in schizophrenia: benefits and risks.Is rational antipsychotic polytherapy feasible? A selective review.Treatment of clozapine-associated weight gain: a systematic review.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Atypical antipsychotics and effects on feeding: from mice to men.Managing comorbid obesity and depression through clinical pharmacotherapies.Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia.Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.Psychiatrists' attitude towards and knowledge of clozapine treatment.A prospective 6-month analysis of the naturalistic use of aripiprazole - factors predicting favourable outcome.A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
P2860
Q24650594-7DA52CB2-C6DC-4C12-BD30-2BDE48D221BCQ34002264-994C3964-5B4A-4B48-B0EF-B91A93152189Q34021447-E8786CF9-69F3-49DE-8EC1-72C4B5F2AE09Q34112064-E5482E0F-75B4-4536-AC27-556F02677ADCQ34966395-FA688727-B72A-46A0-8983-D9AFA05FB11FQ35031175-90A2FC5C-09F2-415E-A0FD-95F2109DCB0CQ35082380-333738D7-F2D1-4CC6-B4A4-FC3C43642304Q35082389-19CA33E4-6447-4990-9A25-13BD5C0BB063Q36026776-527AF9D9-8AF7-4AA6-BF5B-861A80251743Q36062421-9AD59E00-00C0-4027-BFCF-2274AAD5B439Q36661501-433471B1-E0BB-4343-992E-1E90E92ABE0BQ37137001-C3733C7C-001F-4BFA-8BE9-D6546E6BBA85Q37166131-CF414143-3E54-49FB-AD59-70F0BC5253EAQ37209442-84A2CF42-2C09-4CA6-963D-01484F799898Q37281587-43C878AC-CCEB-4563-8668-9921057525E8Q37674020-EB56B399-4D15-4C05-A112-2C63F8B107DCQ37786274-EEC604A2-90A0-48B0-982C-87DA2D5347CCQ37863093-97C0CD80-AD2C-4730-9361-7EBBA5C0882CQ37993473-FFC276F4-4119-49A6-8B8E-F4EB8927A411Q38334922-D945A170-C55B-42EA-916A-195F6040649CQ38769838-2DFF1381-9550-4B9F-A7DE-A5B5C213A001Q38826206-C3C267A5-D9DE-44FC-A16E-A8C364399978Q38850666-D6E20688-0100-4430-8BE9-941DD9122EC5Q38859885-46F2EB26-8C8C-4EC3-94DD-2AB92B84EBFAQ42162953-6CAA8DE2-F8BA-4F6F-AF15-8CB3C4499E42Q42279073-6C424CA2-3618-4EBB-93A3-9E2D75B3E0B0Q43135390-27E194BC-ED12-4C68-9AF0-85EC4BC9F7C9Q44243570-C7D1C4B2-E2C2-478C-8F9F-95BA3EBC9E62Q46150844-9003F6D5-96E0-45F2-A0AF-CF115FCDF541Q46923499-1AD7462D-8BC1-4F26-A23C-6B0AFCF35B4BQ47304572-8B670F66-F7B1-489D-BA13-B7988EB40651Q50773348-5F8D61EE-8510-4226-A1F4-E83377335AFAQ53169797-8A197EB4-7565-4A08-9BE3-B20E6A6EF721
P2860
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@en
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@nl
type
label
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@en
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@nl
prefLabel
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@en
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@nl
P2093
P2860
P1476
An exploratory open-label tria ...... rapy in chronic schizophrenia.
@en
P2093
D C Henderson
D D Nguyen
O Freudenreich
P2860
P304
P356
10.1111/J.1600-0447.2005.00612.X
P407
P577
2006-02-01T00:00:00Z